[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Human Vaccine Market Research Report 2016

October 2016 | 113 pages | ID: GF44D822350EN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Production, means the output of Human Vaccine

Revenue, means the sales value of Human Vaccine

This report studies Human Vaccine in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
  • GSK
  • Merck
  • Novartis
  • Pfizer
  • Sanofi
  • AstraZeneca
  • Johnson & Johnson
  • Bavarian Nordic
  • CSL
  • Emergent Biosolutions
  • Unilab
  • China National Biotec Group
  • Hualan Bio
  • Zhifei
  • Sinovac
  • Walvax
  • Liaoning Chengda
  • Neptunus Group
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Human Vaccine in these regions, from 2011 to 2021 (forecast), like
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
  • Pediatric
  • Adult vaccine
  • Type III
Split by application, this report focuses on consumption, market share and growth rate of Human Vaccine in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
Global Human Vaccine Market Research Report 2016

1 HUMAN VACCINE MARKET OVERVIEW

1.1 Product Overview and Scope of Human Vaccine
1.2 Human Vaccine Segment by Type
  1.2.1 Global Production Market Share of Human Vaccine by Type in 2015
  1.2.2 Pediatric
  1.2.3 Adult vaccine
  1.2.4 Type III
1.3 Human Vaccine Segment by Application
  1.3.1 Human Vaccine Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Human Vaccine Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Human Vaccine (2011-2021)

2 GLOBAL HUMAN VACCINE MARKET COMPETITION BY MANUFACTURERS

2.1 Global Human Vaccine Production and Share by Manufacturers (2015 and 2016)
2.2 Global Human Vaccine Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Human Vaccine Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Human Vaccine Manufacturing Base Distribution, Sales Area and Product Type
2.5 Human Vaccine Market Competitive Situation and Trends
  2.5.1 Human Vaccine Market Concentration Rate
  2.5.2 Human Vaccine Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL HUMAN VACCINE PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Human Vaccine Production and Market Share by Region (2011-2016)
3.2 Global Human Vaccine Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Human Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Human Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Human Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Human Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Human Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Human Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Human Vaccine Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL HUMAN VACCINE SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Human Vaccine Consumption by Regions (2011-2016)
4.2 North America Human Vaccine Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Human Vaccine Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Human Vaccine Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Human Vaccine Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Human Vaccine Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Human Vaccine Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL HUMAN VACCINE PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Human Vaccine Production and Market Share by Type (2011-2016)
5.2 Global Human Vaccine Revenue and Market Share by Type (2011-2016)
5.3 Global Human Vaccine Price by Type (2011-2016)
5.4 Global Human Vaccine Production Growth by Type (2011-2016)

6 GLOBAL HUMAN VACCINE MARKET ANALYSIS BY APPLICATION

6.1 Global Human Vaccine Consumption and Market Share by Application (2011-2016)
6.2 Global Human Vaccine Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL HUMAN VACCINE MANUFACTURERS PROFILES/ANALYSIS

7.1 GSK
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Human Vaccine Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 GSK Human Vaccine Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Merck
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Human Vaccine Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Merck Human Vaccine Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Novartis
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Human Vaccine Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Novartis Human Vaccine Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Pfizer
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Human Vaccine Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Pfizer Human Vaccine Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Sanofi
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Human Vaccine Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Sanofi Human Vaccine Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 AstraZeneca
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Human Vaccine Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 AstraZeneca Human Vaccine Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Johnson & Johnson
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Human Vaccine Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Johnson & Johnson Human Vaccine Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Bavarian Nordic
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Human Vaccine Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Bavarian Nordic Human Vaccine Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 CSL
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Human Vaccine Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 CSL Human Vaccine Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Emergent Biosolutions
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Human Vaccine Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Emergent Biosolutions Human Vaccine Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 Unilab
7.12 China National Biotec Group
7.13 Hualan Bio
7.14 Zhifei
7.15 Sinovac
7.16 Walvax
7.17 Liaoning Chengda
7.18 Neptunus Group

8 HUMAN VACCINE MANUFACTURING COST ANALYSIS

8.1 Human Vaccine Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Human Vaccine

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Human Vaccine Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Human Vaccine Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL HUMAN VACCINE MARKET FORECAST (2016-2021)

12.1 Global Human Vaccine Production, Revenue Forecast (2016-2021)
12.2 Global Human Vaccine Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Human Vaccine Production Forecast by Type (2016-2021)
12.4 Global Human Vaccine Consumption Forecast by Application (2016-2021)
12.5 Human Vaccine Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Human Vaccine
Figure Global Production Market Share of Human Vaccine by Type in 2015
Figure Product Picture of Pediatric
Table Major Manufacturers of Pediatric
Figure Product Picture of Adult vaccine
Table Major Manufacturers of Adult vaccine
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Human Vaccine Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Human Vaccine Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Human Vaccine Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Human Vaccine Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Human Vaccine Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Human Vaccine Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Human Vaccine Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Human Vaccine Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Human Vaccine Production of Key Manufacturers (2015 and 2016)
Table Global Human Vaccine Production Share by Manufacturers (2015 and 2016)
Figure 2015 Human Vaccine Production Share by Manufacturers
Figure 2016 Human Vaccine Production Share by Manufacturers
Table Global Human Vaccine Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Human Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Human Vaccine Revenue Share by Manufacturers
Table 2016 Global Human Vaccine Revenue Share by Manufacturers
Table Global Market Human Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Human Vaccine Average Price of Key Manufacturers in 2015
Table Manufacturers Human Vaccine Manufacturing Base Distribution and Sales Area
Table Manufacturers Human Vaccine Product Type
Figure Human Vaccine Market Share of Top 3 Manufacturers
Figure Human Vaccine Market Share of Top 5 Manufacturers
Table Global Human Vaccine Production by Regions (2011-2016)
Figure Global Human Vaccine Production and Market Share by Regions (2011-2016)
Figure Global Human Vaccine Production Market Share by Regions (2011-2016)
Figure 2015 Global Human Vaccine Production Market Share by Regions
Table Global Human Vaccine Revenue by Regions (2011-2016)
Table Global Human Vaccine Revenue Market Share by Regions (2011-2016)
Table 2015 Global Human Vaccine Revenue Market Share by Regions
Table Global Human Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Human Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Human Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Table China Human Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Human Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Human Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Table India Human Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Human Vaccine Consumption Market by Regions (2011-2016)
Table Global Human Vaccine Consumption Market Share by Regions (2011-2016)
Figure Global Human Vaccine Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Human Vaccine Consumption Market Share by Regions
Table North America Human Vaccine Production, Consumption, Import & Export (2011-2016)
Table Europe Human Vaccine Production, Consumption, Import & Export (2011-2016)
Table China Human Vaccine Production, Consumption, Import & Export (2011-2016)
Table Japan Human Vaccine Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Human Vaccine Production, Consumption, Import & Export (2011-2016)
Table India Human Vaccine Production, Consumption, Import & Export (2011-2016)
Table Global Human Vaccine Production by Type (2011-2016)
Table Global Human Vaccine Production Share by Type (2011-2016)
Figure Production Market Share of Human Vaccine by Type (2011-2016)
Figure 2015 Production Market Share of Human Vaccine by Type
Table Global Human Vaccine Revenue by Type (2011-2016)
Table Global Human Vaccine Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Human Vaccine by Type (2011-2016)
Figure 2015 Revenue Market Share of Human Vaccine by Type
Table Global Human Vaccine Price by Type (2011-2016)
Figure Global Human Vaccine Production Growth by Type (2011-2016)
Table Global Human Vaccine Consumption by Application (2011-2016)
Table Global Human Vaccine Consumption Market Share by Application (2011-2016)
Figure Global Human Vaccine Consumption Market Share by Application in 2015
Table Global Human Vaccine Consumption Growth Rate by Application (2011-2016)
Figure Global Human Vaccine Consumption Growth Rate by Application (2011-2016)
Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GSK Human Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Figure GSK Human Vaccine Market Share (2011-2016)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Human Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Human Vaccine Market Share (2011-2016)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Human Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Human Vaccine Market Share (2011-2016)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Human Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Human Vaccine Market Share (2011-2016)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Human Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi Human Vaccine Market Share (2011-2016)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Human Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca Human Vaccine Market Share (2011-2016)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Human Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson Human Vaccine Market Share (2011-2016)
Table Bavarian Nordic Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bavarian Nordic Human Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bavarian Nordic Human Vaccine Market Share (2011-2016)
Table CSL Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Human Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Figure CSL Human Vaccine Market Share (2011-2016)
Table Emergent Biosolutions Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Emergent Biosolutions Human Vaccine Production, Revenue, Price and Gross Margin (2011-2016)
Figure Emergent Biosolutions Human Vaccine Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Vaccine
Figure Manufacturing Process Analysis of Human Vaccine
Figure Human Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Human Vaccine Major Manufacturers in 2015
Table Major Buyers of Human Vaccine
Table Distributors/Traders List
Figure Global Human Vaccine Production and Growth Rate Forecast (2016-2021)
Figure Global Human Vaccine Revenue and Growth Rate Forecast (2016-2021)
Table Global Human Vaccine Production Forecast by Regions (2016-2021)
Table Global Human Vaccine Consumption Forecast by Regions (2016-2021)
Table Global Human Vaccine Production Forecast by Type (2016-2021)
Table Global Human Vaccine Consumption Forecast by Application (2016-2021)


More Publications